Caxton Associates (New York)’s PDL BioPharma, Inc. PDLI Stock Holding History

Caxton Associates (New York)’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-87,446	Closed	-$275K	–	378
2020 Q3	$275K	Buy	+87,446	New	+$279K	0.03%	211
2020 Q1	–	Sell	-262,508	Closed	-$852K	–	663
2019 Q4	$852K	Buy	262,508 +186,488	+245%	+$541K	0.12%	105
2019 Q3	$164K	Sell	76,020 -7,040	-8%	-$18.8K	0.03%	355
2019 Q2	$261K	Sell	83,060 -123,413	-60%	-$400K	0.03%	314
2019 Q1	$768K	Buy	+206,473	New	+$697K	0.11%	95
2018 Q3	–	Sell	-45,069	Closed	-$105K	–	575
2018 Q2	$105K	Buy	+45,069	New	+$126K	0.01%	360

Other funds holding PDLI

Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

California Public Employees Retirement System

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Russell Investments Group

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return